6XBG

Target information

RCSB PDB
6XBG
Title
Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW246
Method
X-RAY DIFFRACTION
Resolution
1.45
Classification
HYDROLASE/HYDROLASE INHIBITOR
Organism
Severe acute respiratory syndrome coronavirus 2, synthetic construct
Protein
Replicase polyprotein 1ab (P0DTD1)    Looking for covalent inhibitors of this target ?
Year
2020
Publication Title
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L.
Abstract

The main protease (M pro ) of SARS-CoV-2 is a key antiviral drug target. While most M pro inhibitors have a ??-lactam glutamine surrogate at the P1 position, we recently found that several M pro inhibitors have hydrophobic moieties at the P1 site, including calpain inhibitors II and XII, which are also active against human cathepsin L, a host protease that is important for viral entry. In this study, we solved x-ray crystal structures of M pro in complex with calpain inhibitors II and XII and three analogs of GC-376 The structure of M pro with calpain inhibitor II confirmed that the S1 pocket can accommodate a hydrophobic methionine side chain, challenging the idea that a hydrophilic residue is necessary at this position. The structure of calpain inhibitor XII revealed an unexpected, inverted binding pose. Together, the biochemical, computational, structural, and cellular data presented herein provide new directions for the development of dual inhibitors as SARS-CoV-2 antivirals.

External Link
RCSB PDB





Ligand information

HET
UZ4
Chain ID
C
HET Number
3
Molecular Formula
C25H34N4O6
Structure
2D structure
IUPAC Name
benzyl N-[(1S)-1-[[(1S)-3-(cyclopropylamino)-2,3-dioxo-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]propyl]carbamoyl]-3-methyl-butyl]carbamate
InChI
InChI=1S/C25H34N4O6/c1-15(2)12-20(29-25(34)35-14-16-6-4-3-5-7-16)23(32)28-19(13-17-10-11-26-22(17)31)21(30)24(33)27-18-8-9-18/h3-7,15,17-20H,8-14H2,1-2H3,(H,26,31)(H,27,33)(H,28,32)(H,29,34)/t17-,19-,20-/m0/s1
InChI Key
OFRZKNOAEKYJPI-IHPCNDPISA-N
Canonical SMILES
O=C1NCC[C@H]1C[C@@H](C(=O)C(=O)NC2CC2)NC(=O)[C@H](CC(C)C)NC(=O)OCc3ccccc3
Bioactivity data
CI006856

Covalent Binding

Warhead
Carbonyl
Reaction Mechanism
Nucleophilic Addition
Residue
CYS : 145
Residue Chain
A
Interactions
Pharmacophore Model



Ligand information

HET
UZ4
Chain ID
C
HET Number
3
Molecular Formula
C25H34N4O6
Structure
2D structure
IUPAC Name
benzyl N-[(1S)-1-[[(1S)-3-(cyclopropylamino)-2,3-dioxo-1-[[(3S)-2-oxopyrrolidin-3-yl]methyl]propyl]carbamoyl]-3-methyl-butyl]carbamate
InChI
InChI=1S/C25H34N4O6/c1-15(2)12-20(29-25(34)35-14-16-6-4-3-5-7-16)23(32)28-19(13-17-10-11-26-22(17)31)21(30)24(33)27-18-8-9-18/h3-7,15,17-20H,8-14H2,1-2H3,(H,26,31)(H,27,33)(H,28,32)(H,29,34)/t17-,19-,20-/m0/s1
InChI Key
OFRZKNOAEKYJPI-IHPCNDPISA-N
Canonical SMILES
O=C1NCC[C@H]1C[C@@H](C(=O)C(=O)NC2CC2)NC(=O)[C@H](CC(C)C)NC(=O)OCc3ccccc3
Bioactivity data
CI006856

Covalent Binding

Warhead
Carbonyl
Reaction Mechanism
Nucleophilic Addition
Residue
CYS : 145
Residue Chain
A
Interactions
Pharmacophore Model